| NCT06983028 | Atacicept in Multiple Glomerular Diseases | RECRUITING | PHASE2 | 2025-07-07 | 2027-11 | 2027-11 |
| NCT07020923 | Monthly Dosing of Atacicept in IgAN | RECRUITING | PHASE2 | 2025-05-29 | 2027-09 | 2026-09 |
| NCT06674577 | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept | ENROLLING_BY_INVITATION | PHASE2 | 2024-12-01 | 2028-05-31 | 2028-05-31 |
| NCT04716231 | Atacicept in Subjects With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-06-29 | 2028-07 | 2025-05-15 |
| NCT05609812 | Atacicept in Subjects With Active Lupus Nephritis (COMPASS) | WITHDRAWN | PHASE3 | 2022-11-02 | 2028-12-15 | 2026-03-15 |
| NCT04294472 | A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients | COMPLETED | PHASE2 | 2020-08-05 | 2022-02-10 | 2022-02-10 |